Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study

被引:102
作者
Schaefer, EJ
McNamara, JR
Shah, PK
Nakajima, K
Cupples, LA
Ordovas, JM
Wilson, PWF
机构
[1] Tufts Univ New England Med Ctr, Lipid Res Lab, Div Endocrinol Diabet Metab & Mol Med, Boston, MA 02111 USA
[2] Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA
[3] Otsuka Amer Pharmaceut Inc, Rockville, MD USA
[4] NHLBI, Framingham Heart Study, NIH, Framingham, MA USA
关键词
D O I
10.2337/diacare.25.6.989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Remnants of triglyceride-rich lipoproteins are thought to be atherogenic. A new antibody-based assay allows for the isolation of remnant-like particles (RLPs) from plasma or serum, and the subsequent measurement of RLP cholesterol (RLPC) and triglycerides (RLPTGs). We hypothesized that diabetic patients would have higher remnant levels than nondiabetic patients. DESIGN AND METHODS - We compared RLPC and RLPTG levels of diabetic subjects (68 women, 121 men) participating in the Framingham Heart Study with those of nondiabetic subjects (1,499 women, 1,357 men). RESULTS - Mean RLPC values for diabetic women were 106% higher than those for nondiabetic women (0.367 +/- 0.546 mmol/l [14.2 +/- 21.1 mg/dl] vs. 0.179 +/- 0.1.09 mmol/l 16.9 +/- 14.2 mg/dl]; P < 0.0001), and RLPTG values for diabetic women were 385% higher than those for nondiabetic women (1.089 +/- 2.775 mmol/l [93.1 +/- 245.6 mg/dl] vs. 0.217 +/- 0.235 mmol/l [19.2 +/- 20.8 mg/dl]; P < 0.0001). Similar but less striking differences were observed in diabetic men, who had mean RLPC values 28% higher than those seen in nondiabetic men (0.285 +/- 0.261 mmol/l [11.0 +/- 10.1 mg/dl] vs. 0.223 +/- 0.163 mmol/l [8.6 +/- 6.3 mg/dl]; P < 0.001) and mean RLPTG values 70% higher than those seen in nondiabetic men (0.606 +/- 1.019 mmol/l [53.6 +/- 90.2 mg/dl] vs. 0.357 +/- 0.546 mmol/l [31.6 +/- 48.3 mg/dl] P < 0.001). Moreover, diabetic men and women had significantly higher total triglycerides and lower HDL cholesterol levels than nondiabetic subjects. CONCLUSIONS - The data indicate that RLP particles are elevated in diabetic subjects. To achieve optimal reduction of risk for cardiovascular disease, treatment of elevated RLP values, along with the control of LDL cholesterol levels, should be considered.
引用
收藏
页码:989 / 994
页数:6
相关论文
共 25 条
  • [1] TYPE-III HYPERLIPOPROTEINEMIA - DIAGNOSIS, MOLECULAR DEFECTS, PATHOLOGY, AND TREATMENT
    BREWER, HB
    ZECH, LA
    GREGG, RE
    SCHWARTZ, D
    SCHAEFER, EJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 623 - 640
  • [2] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [3] Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
    Devaraj, S
    Vega, G
    Lange, R
    Grundy, SM
    Jialal, I
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) : 445 - 450
  • [4] Ratio of remnant-like particle cholesterol to serum total triglycerides is a reliable screening test for type III dyslipidaemia
    Devaraj, S
    Hirany, S
    Jialal, I
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2000, 37 : 790 - 791
  • [5] Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation
    Doi, H
    Kugiyama, K
    Ohgushi, M
    Sugiyama, S
    Matsumura, T
    Ohta, Y
    Oka, H
    Ogata, N
    Hirata, A
    Yamamoto, Y
    Yasue, H
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) : 1918 - 1924
  • [6] HDL-CHOLESTEROL AS A RISK FACTOR IN CORONARY HEART-DISEASE - AN UPDATE OF THE HELSINKI HEART-STUDY
    FRICK, MH
    MANNINEN, V
    HUTTUNEN, JK
    HEINONEN, OP
    TENKANEN, L
    MANTTARI, M
    [J]. DRUGS, 1990, 40 : 7 - 12
  • [7] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
  • [8] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [9] FAMILIAL LIPOPROTEIN DISORDERS IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE
    GENEST, JJ
    MARTINMUNLEY, SS
    MCNAMARA, JR
    ORDOVAS, JM
    JENNER, J
    MYERS, RH
    SILBERMAN, SR
    WILSON, PWF
    SALEM, DN
    SCHAEFER, EJ
    [J]. CIRCULATION, 1992, 85 (06) : 2025 - 2033
  • [10] Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014